New imaging agent aims to unmask hidden prostate cancer recurrences
NCT ID NCT06813898
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This trial tests whether a special PET/CT scan using a tracer called POSLUMA can detect prostate cancer in men whose PSA levels are rising after treatment but who had negative results on standard PET scans. The study enrolls men with biochemical recurrence and low PSA levels. Researchers will compare the scan findings to tissue samples or follow-up imaging to see how often POSLUMA spots cancer that other scans missed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Flotufolastat F-18 Gallium (POSLUMA)
What this could lead to
If successful, this imaging method could help doctors find hidden prostate cancer recurrences earlier, guiding more precise treatment.
What could go wrong
This is an early-phase trial with only 27 participants, so results may not apply broadly. The scan might still miss some cancers or find false positives.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- rhPSMA-PET MRI for Prostate Cancer Detection - NCT05852041
- CV CARE: Heart Health in Prostate Cancer ADT (NCT06202820)
- OCEAN Trial: PSMA-Directed Radiation for Prostat NCT06392295
- Prostate Cancer Trial: Lu-PSMA & Hormone Therapy NCT07650240
- Study of Double-Positive Cells in Metastatic Can NCT06967961
- Intra-Arterial PSMA Injection in Prostate Cancer NCT07656337
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact